GENB · ISSUER CIK 2100782
Generate Biomedicines, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Generate Biomedicines, Inc. insiders reported $0.00 of open-market purchases and $16K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$16KInsider selling
−$16KNet open-market
Sep 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:05 | Sep 1, 2026 | GENB | Director | S · Sell10b5-1 | $16.00 | −1,000 | 231,472 | -0% | −$16K |